MedTrace Logo

Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation

NCT00263406 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-12-28

No results posted yet for this study

Summary

Randomisation between postoperative administration of an ACE-inhibitor or not.

Conditions

  • Children With a Univentricular Heart Undergoing Surgery for Creation of a Fontan Circulation

Interventions

DRUG

Administration of an ACE-inhibitor or not

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Guy Van Nooten, MD, PhD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-31
Completion
2007-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263406 on ClinicalTrials.gov